NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 48 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $43,285 | +98275.0% | 233,973 | 0.0% | 0.00% | – |
| Q4 2022 | $44 | -100.0% | 233,973 | -0.3% | 0.00% | – |
| Q3 2022 | $92,000 | -62.6% | 234,571 | 0.0% | 0.00% | – |
| Q2 2022 | $246,000 | -46.3% | 234,571 | -3.9% | 0.00% | – |
| Q1 2022 | $458,000 | -33.1% | 243,984 | 0.0% | 0.00% | – |
| Q4 2021 | $685,000 | -20.8% | 243,984 | +1.7% | 0.00% | – |
| Q3 2021 | $865,000 | -22.8% | 239,819 | +2.5% | 0.00% | – |
| Q2 2021 | $1,120,000 | -52.0% | 233,856 | -25.9% | 0.00% | – |
| Q1 2021 | $2,331,000 | +31.4% | 315,525 | +24.3% | 0.00% | – |
| Q4 2020 | $1,774,000 | -2.2% | 253,930 | +6.2% | 0.00% | – |
| Q3 2020 | $1,814,000 | +35.6% | 239,117 | +56.8% | 0.00% | – |
| Q2 2020 | $1,338,000 | +1063.5% | 152,486 | +840.9% | 0.00% | – |
| Q1 2020 | $115,000 | -50.4% | 16,206 | -50.0% | 0.00% | – |
| Q4 2019 | $232,000 | +193.7% | 32,412 | +103.1% | 0.00% | – |
| Q3 2019 | $79,000 | – | 15,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |